The Importance of Anemia and its Correction in the Management of Severe Congestive Heart Failures
- 25 November 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 4 (6) , 681-686
Abstract
About half of all the patients with CHF are anemic (they have a hemoglobin of <12 g%). The prevalence and severity of this anemia increase with increasing severity of the CHF. The anemia is caused by a combination of poor nutrition, associated renal insufficiency causing inappropriately low Erythropoietin (EPO) levels, bone marrow depression and EPO resistance caused by excessive TNF alpha and other factors, gastrointestinal blood loss caused by aspirin, ACE inhibitors, EPO loss in the urine with proteinuria, and hemodilution caused by the excessive plasma volume. Studies have shown that the anemia is an independent risk factor for death in CHF, almost doubling the mortality rate. Correction of the anemia with subcutaneous EPO and IV iron improves cardiac function and functional capacity, helps prevent the progression of renal failure, markedly reduces hospitalization and diuretic doses, and improves self assessed quality of life. This so-called Cardio Renal Anemia Syndrome is very common in CHF. Its successful treatment demands close cooperation between cardiologists and nephrologists.Keywords
This publication has 27 references indexed in Scilit:
- Anemia, Transfusion, and MortalityNew England Journal of Medicine, 2001
- Survival of patients with a new diagnosis of heart failure: a population based studyHeart, 2000
- An overview of tumor necrosis factor α and the failing human heartCurrent Opinion in Cardiology, 1999
- Chairman's workshop report. What are The short-term and long-term consequences of anaemia in CRF patients?Nephrology Dialysis Transplantation, 1999
- Normal Reference Laboratory ValuesNew England Journal of Medicine, 1998
- The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and EpoetinNew England Journal of Medicine, 1998
- Intravenous Ferric Saccharate as an Iron Supplement in Dialysis PatientsNephron, 1996
- Morbidity risk assessment in the surgically anemic patientThe American Journal of Surgery, 1995
- Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profilesThe American Journal of Cardiology, 1994
- Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.Heart, 1993